Welcome to Traders.com Advantage!

TECHNICAL ANALYSIS  |  April 30, 2020
Eli Lilly
The National Institute for Health (NIH) and the Foundation for the NIH (FNIH) announced on April 17, 2020 via a news release that they are bringing together sixteen of the leading biopharmaceutical companies in conjunction with other national and international agencies to develop "an international strategy for a coordinated research response to the COVID-19 pandemic." One of these leading pharmaceutical companies is Eli Lilly and Company (LLY).
by Stella Osoba, CMT

You must be a registered member of STOCKS & COMMODITIES magazine to read the article you’ve requested.

Simply fill in your name and address and submit this form to us to receive your FREE TRIAL subscription to STOCKS & COMMODITIES.

This will begin your trial subscription at the special introductory rate of only $89.99 for 1 year. You will receive a trial issue of the magazine in the mail and also be able to access a sample digital issue of the magazine online in our subscriber area. In addition, you will have access to our online publications Working Money and Traders.com Advantage for 30 days!. Your log-in information will also be provided via the Email address you submit with the form below.

If you are not satisfied with your sample issue of Stocks & Commodities magazine, just return your bill marked “cancel” and owe nothing. The sample issue is yours to keep!

HELPQuestions or Comments? Send message to: Circ@Traders.com